[1]Patent:WO2010/372,2010,A2.Locationinpatent:Page/Pagecolumn32
[1]Patent:WO2010/372,2010,A2.Locationinpatent:Page/Pagecolumn32
[1]Patent:WO2010/372,2010,A2.Locationinpatent:Page/Pagecolumn47
[1]Patent:WO2017/102893,2017,A1.Locationinpatent:Page/Pagecolumn18;19
[1]Patent:WO2017/102893,2017,A1.Locationinpatent:Page/Pagecolumn18;19
Title: Wagner J, et al. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathol. 2013 Jun;125(6):795-813.
Title: Martinez Hernandez A, et al. The diphenylpyrazole compound anle138b blocks Aβ channels and rescues disease phenotypes in a mouse model for amyloid pathology. EMBO Mol Med. 2018;10(1):32-47.
Title: Heras-Garvin A, et al. Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy. Mov Disord. 2019;34(2):255-263.
